Wulong J. Liang

Zhengzhou Key Laboratory Of Lipid Metabolism And Precision Diagnosis & Treatment In Oncology
Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies.

Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies.

Journal: Frontiers in immunology
Published: June 24, 2026

A multicohort machine-learning prognostic signature reveals inflammatory immune remodeling and statin sensitivity in glioblastoma.

A multicohort machine-learning prognostic signature reveals inflammatory immune remodeling and statin sensitivity in glioblastoma.

Journal: Frontiers in oncology
Published: June 17, 2026

MLN4924 enhances RSL3-induced ferroptosis sensitivity in glioblastoma via inhibiting the STAT3/GPX4 axis.

MLN4924 enhances RSL3-induced ferroptosis sensitivity in glioblastoma via inhibiting the STAT3/GPX4 axis.

Journal: Carcinogenesis
Published: February 23, 2026

Overcoming chemoresistance in esophageal cancer with synergistic strategies.

Overcoming chemoresistance in esophageal cancer with synergistic strategies.

Journal: Frontiers in immunology
Published: January 09, 2026

Caspase-3 activation is a brake in GSDMD-mediated pyroptosis.

Caspase-3 activation is a brake in GSDMD-mediated pyroptosis.

Journal: Cellular signalling
Published: January 08, 2026

Finely-tuned regulator of DNA repair: FBXW7-185aa may modulate glioblastoma radiosensitization and the tumor immune microenvironment.

Finely-tuned regulator of DNA repair: FBXW7-185aa may modulate glioblastoma radiosensitization and the tumor immune microenvironment.

Journal: Translational oncology
Published: January 05, 2026

PARP4 drives tumor progression by promoting glioma cell proliferation and invasion as a potential therapeutic target.

PARP4 drives tumor progression by promoting glioma cell proliferation and invasion as a potential therapeutic target.

Journal: Discover oncology
Published: December 04, 2025

Comprehensive analysis of mitochondria-associated genes in glioblastoma via single-cell and bulk RNA sequencing.

Comprehensive analysis of mitochondria-associated genes in glioblastoma via single-cell and bulk RNA sequencing.

Journal: Discover oncology
Published: July 25, 2025

SOAT1 expression associates with prognosis, immune environment and biochemical indicators in glioma.

SOAT1 expression associates with prognosis, immune environment and biochemical indicators in glioma.

Journal: Discover oncology
Published: July 16, 2025

Chemically induced dimerization of GSDMD C-terminal domain blocks GSDMD N-terminal domain-mediated pyroptosis.

Chemically induced dimerization of GSDMD C-terminal domain blocks GSDMD N-terminal domain-mediated pyroptosis.

Journal: Cell death discovery
Published: April 13, 2025

The dual roles of chemokines in peripheral nerve injury and repair.

The dual roles of chemokines in peripheral nerve injury and repair.

Journal: Inflammation and regeneration
Published: January 08, 2025

RNF7-Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes.

RNF7-Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes.

Journal: Molecular carcinogenesis
Published: November 12, 2024
Showing 1-12 of 52

Last Updated: 09/26/2026